No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
European Equities Traded in the US as American Depositary Decline in Tuesday Trading
NuCana Plc Reports Encouraging Clinical Data for NUC-7738 and NUC-3373, Highlights Financial Position and Future Milestones
Nucana Reports Third Quarter Loss Amid R&D Investments
NuCana Q3 2024 GAAP EPS Of £(0.07) Versus £(0.13) YoY, Cash And Cash Equivalents Of £11.4M Expected To Provide Cash Runway Into Q2 2025
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
NuCana Had Cash and Cash Equivalents of GBP11.4M at Sept 30 >NCNA
No Data